Han, D.; Spehar, J.M.; Richardson, D.S.; Leelananda, S.; Chakravarthy, P.; Grecco, S.; Reardon, J.; Stover, D.G.; Bennett, C.; Sizemore, G.M.;
et al. The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer. Cancers 2024, 16, 3043.
https://doi.org/10.3390/cancers16173043
AMA Style
Han D, Spehar JM, Richardson DS, Leelananda S, Chakravarthy P, Grecco S, Reardon J, Stover DG, Bennett C, Sizemore GM,
et al. The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer. Cancers. 2024; 16(17):3043.
https://doi.org/10.3390/cancers16173043
Chicago/Turabian Style
Han, David, Jonathan M. Spehar, Dillon S. Richardson, Sumudu Leelananda, Prathik Chakravarthy, Samantha Grecco, Jesse Reardon, Daniel G. Stover, Chad Bennett, Gina M. Sizemore,
and et al. 2024. "The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer" Cancers 16, no. 17: 3043.
https://doi.org/10.3390/cancers16173043
APA Style
Han, D., Spehar, J. M., Richardson, D. S., Leelananda, S., Chakravarthy, P., Grecco, S., Reardon, J., Stover, D. G., Bennett, C., Sizemore, G. M., Li, Z., Lindert, S., & Sizemore, S. T.
(2024). The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer. Cancers, 16(17), 3043.
https://doi.org/10.3390/cancers16173043
